Atlas Trials

Study to Assess the Effect of Long-term Treatment With Voxelotor in Participants Who Have Completed Treatment in Study GBT440-031

Clinical trial NCT03573882 · TERMINATED

Trial details

NCT number
NCT03573882
Sponsor
Pfizer
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Sickle Cell Disease
Start date
2018-06-06
Primary completion
2024-11-12
Enrollment
179

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.